Mihelic Marko, Turk Dusan
Department of Biochemistry, Molecular and Structural Biology, Jozef Stefan Institute, Jamova 39, SI-1000, Ljubljana, Slovenia.
Biol Chem. 2007 Nov;388(11):1123-30. doi: 10.1515/BC.2007.155.
Thyroglobulin type-1 repeats are primarily found in thyroglobulin and several other functionally unrelated proteins. Because a few of them exhibit inhibitory activity against cysteine proteases they were named thyropins (thyroglobulin type-1 domain protease inhibitors). In contrast to cystatins, the best-characterized group of papain-like protease inhibitors, they exhibit greater selectivity in their interactions with target proteases. Interestingly, a few members inhibit aspartic protease cathepsin D and metalloproteases. In contrast to the inhibitory fragment of the major histocompatibility complex class II-associated p41 form of invariant chain, whose structural integrity appears mandatory for its inhibitory properties, short polypeptides derived from insulin-like growth factor-binding proteins exhibit the same activity as the structure of the whole fragment. Taken together, the results indicate that the thyroglobulin type-1 repeat is a structural motif occasionally employed as an inhibitor of proteases.
1型甲状腺球蛋白重复序列主要存在于甲状腺球蛋白和其他几种功能不相关的蛋白质中。由于其中一些对半胱氨酸蛋白酶具有抑制活性,因此被命名为甲状腺素(1型甲状腺球蛋白结构域蛋白酶抑制剂)。与木瓜蛋白酶样蛋白酶抑制剂中特征最明确的胱抑素不同,它们在与靶蛋白酶的相互作用中表现出更高的选择性。有趣的是,一些成员可抑制天冬氨酸蛋白酶组织蛋白酶D和金属蛋白酶。与主要组织相容性复合体II类相关恒定链p41形式的抑制片段相反,其结构完整性似乎对其抑制特性至关重要,源自胰岛素样生长因子结合蛋白的短多肽表现出与整个片段结构相同的活性。综上所述,结果表明1型甲状腺球蛋白重复序列是一种偶尔用作蛋白酶抑制剂的结构基序。